Mark Drost

Mark Drost is a Researcher in the Clinical Genetics department at Erasmus University Medical Center (Erasmus MC), Rotterdam. His work focuses on advanced genetic diagnostics with emphasis on prenatal and neurodevelopmental applications.

His research spans Medical Genetics, Molecular Diagnostics, and Prenatal Genetics, with specific expertise in DNA methylation analysis, exome sequencing, and Lynch syndrome variant classification. Key methodologies include chorionic villus sampling optimization, trisomy detection protocols, and functional assay development for genetic variant interpretation.

Analysis of his recent publications reveals strong focus on clinical implementation of genomic technologies, particularly in prenatal diagnostics (2020-2025). His work demonstrates increasing translation of research into clinical practice, with 2024-2025 publications emphasizing routine diagnostic applications of DNA-methylation signatures and exome sequencing. The research consistently addresses high-impact clinical challenges in trisomy confirmation and neurodevelopmental disorder diagnostics.

No scientific awards were documented in the provided materials.

Dr. Drost collaborates extensively across Erasmus MC's clinical genetics teams, with co-authorship spanning diagnostic laboratory staff, clinicians, and researchers. His work involves significant grant-supported projects in prenatal genomics and cancer predisposition syndromes, though specific grant details weren't provided.

He operates within Erasmus MC's Clinical Genetics department infrastructure, contributing to diagnostic pipelines for trisomy detection, exome sequencing interpretation, and Lynch syndrome variant classification. His research integrates laboratory diagnostics with clinical applications through multidisciplinary teams focused on improving genetic diagnostic yield.